QAspire

JANUARY 24, 2010

He was a marketing executive with a large pharmaceutical company when he decided to pursue his calling and start a fitness center. “ You get almost nothing without going through some kind of pain, unless you win a lottery.”, replied the man who was himself a fitness freak. He neither had space nor money to start out.

Directory 84

Directory Blog Pharmaceuticals Quality 84

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

AUGUST 3, 2012

Their reliance on alliances and licenses has increased in both product development and marketing and they have become aggressive acquirers. So far have they moved, in fact, that they sometimes sound as if they have altogether abandoned their commitment to internal development. Nonetheless we counsel CEOs to mind the rhetoric.

Licensing 12

Licensing Depreciation Pharmaceuticals Budgeting 12

Harvard Business Review

DECEMBER 12, 2012

Based on data covering the period from 2005 to 2011, it charts how globalization has evolved since the onset of the financial crisis at the global, regional, and national levels. We compare the depth and breadth of 20 industries' global connectedness before delving into three case studies: pharmaceuticals, passenger cars and mobile phones.

Report 15

Report Merchandising GDP Globalization 15

Harvard Business Review

FEBRUARY 15, 2012

While Guangdong's exports accounted for as much as 37% of China's exports by 2000, its share dropped to 28% in 2011. The province's exports growth rate, which was 26% in 2010, fell to 22% in the first nine months of 2011, and it has continued to decline ever since. Look at the data.

GDP 11

GDP Pharmaceuticals Long-term Globalization 11

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JUNE 29, 2015

To get a better picture of this trend, Stiebale, along with Kevin Amess from Nottingham University Business School and Mike Wright from Imperial College Business School, analyzed hundreds of PE-backed LBOs of UK companies from 1998 to 2008. For a refresher on how PE works, see The Strategic Secret of Private Equity.)

LBO 8

LBO Innovation Sample Short-term 8